Kidney cancer

Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis
Bisheng Cheng, Jilin Wu, Ke Chen, Weijia Li, Jianghua Yang, WenTai Shangguan, Lin Yang, Wenxue Huang, Cunzhen Ma, Zhuohang Li, Boyuan Sun, Qiong Wang, Hai Huang, Peng Wu

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e011154; DOI: 10.1136/jitc-2024-011154
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Kiran L Malikayil, Devaki Shilpa Surasi, Tharakeswara K Bathala, Yiyun Lin, Priya Rao, Pheroze Tamboli, Kanishka Sircar, Helen Ajufo, Khaled M Elsayes, Amishi Shah, Andrew C Johns, Sangeeta Goswami, Elshad Hasanov, Eric Jonasch, Pavlos Msaouel, Matthew T Campbell, Omar Alhalabi, Nizar M Tannir

Journal for ImmunoTherapy of Cancer Feb 2025, 13 (2) e010958; DOI: 10.1136/jitc-2024-010958
Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma
Xiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, Virginie Verkarre, Cheng-Ming Sun, Wenxuan Cheng, Li Xu, Fangrong Yan, Salma Kotti, Wolf Hervé Fridman, Catherine Sautes-Fridman, Stéphane Oudard, Gabriel G. Malouf

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010386; DOI: 10.1136/jitc-2024-010386
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
Yanyan Zheng, Jiawei Wang, Guangya Zhao, Zichun Zhang, Yingxiang Shao, Bowen Lu, Yuchen Zhang, Renjin Chen, Li Sun, Xiaohui Xie, Jiage Ding, Junnian Zheng, Dafei Chai

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010521; DOI: 10.1136/jitc-2024-010521
Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma
Xiyu Song, Yumeng Zhu, Wenwen Geng, Jianhua Jiao, Hongjiao Liu, Ruo Chen, Qian He, Lijuan Wang, Xiuxuan Sun, Weijun Qin, Jiejie Geng, Zhinan Chen

Journal for ImmunoTherapy of Cancer Jan 2025, 13 (1) e010183; DOI: 10.1136/jitc-2024-010183
VHL missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response
Ziyang Xu, Li Liu, Wenbin Jiang, Youqi Qiu, Boyu Zhang, Jiangting Cheng, Jiyan Luo, Jianming Guo, Jiejie Xu

Journal for ImmunoTherapy of Cancer Oct 2024, 12 (10) e009963; DOI: 10.1136/jitc-2024-009963
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus
Stefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, Timothy T Spear, Ujjawal Savani, Stephanie Pierre, Gina M Scurti, Long Chen, Muna Igboko, Rosa Nadal, Gang Zeng, Gordon Parry, David F Stroncek, Steven Highfill, Annika V Dalheim, Robert Reger, Michael I Nishimura, Richard W Childs

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (9) e009147; DOI: 10.1136/jitc-2024-009147
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214
Charlene M Mantia, Opeyemi A Jegede, Elizabeth R Plimack, Thomas Powles, Robert J Motzer, Nizar M Tannir, Chung-Han Lee, Yoshihiko Tomita, Martin H Voss, Toni K Choueiri, Brian I Rini, Hans J Hammers, Bernard Escudier, Laurence Albigès, Lisa Rosenblatt, Michael B Atkins, Meredith M Regan, David F McDermott

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009495; DOI: 10.1136/jitc-2024-009495
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study
Yu-Qi Wang, Wen-Jin Chen, Wang Zhou, Ke-Qin Dong, Li Zuo, Da Xu, Jia-Xin Chen, Wei-Jie Chen, Wen-Yan Li, Zi-Chang Liu, Zheng-Yu Jiang, Yi-Fan Tang, Yu-Xuan Qin, Lin-Hui Wang, Xiu-Wu Pan, Xin-Gang Cui

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008613; DOI: 10.1136/jitc-2023-008613
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma
Ryan P O’Connell, Kevin Liaw, Nils Wellhausen, Christopher A Chuckran, Pratik S Bhojnagarwala, Devivasha Bordoloi, Daniel Park, Nicholas Shupin, Daniel Kulp, Carl H June, David Weiner

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008733; DOI: 10.1136/jitc-2023-008733

Main menu

Kidney cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Kidney cancer

Pages